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Optimizing supervised exercise therapy for
patients with intermittent claudication
Saskia P.A. Nicolaï, MD, PhD,a Erik J.M. Hendriks, PhD,b Martin H. Prins, MD, PhD,b and
Joep A.W. Teijink, MD, PhD,b,c on behalf of the EXITPAD study group, Veldhoven, Maastricht, and
Eindhoven, The Netherlands
Background: The first-line intervention for intermittent claudication is usually supervised exercise therapy (SET). The
literature describes a range of exercise programs varying in setting, duration, and content. The purpose of the present
study was to examine the exercise protocols offered and to identify the impact of the intensity of the SET programs (in
terms of frequency, duration, and type of exercise) on improvements in walking distance (response) in the first 3 months.
The present study is part of the Exercise Therapy in Peripheral Arterial Disease (EXITPAD) study, a multicenter
randomized clinical trial comparing the effects of SET provided by regional physiotherapists, with or without daily
feedback, on the level of activities with the effects of walking advice.
Methods: The analysis included patients randomized to receive SET with or without feedback. The physical therapists
administering the SET were asked to fill out therapy evaluation sheets stating frequency, duration, and type of exercises.
The relationship between training volume and the impact on walking distance was explored by dividing training volume
data into tertiles and relating them to the median change in maximum walking distance at 3 and 12 months.
Results: Data of 169 patients were included in the analysis. A SET program consisting of at least two training sessions per
week each lasting over 30 minutes, during the first 3 months of a 1-year program tailored to individual patients’ needs
led to better results in terms of walking distance after 3 and 12 months than the other variants. The results of our analysis
dividing training volume into tertiles suggest that there is a relationship between training volume and improvement in
walking distance and that at least 590 minutes of training should be offered in the first 3 months. No differences were
found between program involving only walking and a combination of exercises, nor between individual and group
training.
Conclusion: A SET programs consisting of at least two training sessions a week, each lasting over 30 minutes, should be
offered during the first 3 months of the SET program to optimize improvement in terms of maximum walking distance.
(J Vasc Surg 2010;52:1226-33.)Symptomatic peripheral arterial disease (PAD) is char-
acterized by leg pain during exertion, which disappears in
rest. Atherosclerosis leads to narrowing of the arteries,
resulting in ischemic pain. Treatment for symptomatic re-
lief consists of conservative and/or invasive therapy. The
first-line conservative therapy usually takes the form of
supervised exercise therapy (SET), which is known to in-
crease walking distance and quality of life.1
SET has been shown to offer added benefit over unsu-
pervised exercise therapy. The literature describes a range
of exercise programs, varying in terms of setting, duration,
and content. In The Netherlands, SET is prescribed ac-
cording to the evidence-based guideline on “intermittent
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1226claudication” of the Royal Dutch Society for Physical Ther-
apy.2 This guideline provides recommendations about the
content and duration of SET. The main goals are symptom
relief and cardiovascular risk factor management. Objec-
tives include increasing maximum walking distance, in-
creasing aerobic endurance, increasing pain tolerance, re-
ducing fear of pain, improving gait pattern and walking
efficiency, improving patient-specific activity limitations
(stair climbing, etc), providing information, and inducing
lifestyle changes. However, the guideline prescribes no
stringent exercise protocol, and physical therapists are ad-
vised to tailor the content and duration of the program to
the individual patient’s needs. The aim of the present study
was to survey the tailored exercise protocols that are being
offered and to identify the impact of the intensity of these
SET programs, in terms of frequency, duration, and type of
exercise, on the improvement in walking distance.
METHODS
This study involved a secondary analysis of data from the
Exercise Therapy in Peripheral Arterial Disease (EXITPAD)
study, a multicenter randomized clinical trial with three
treatment arms; a walking advice (WA), SET, and SETwith
daily therapy feedback.1
A more extensive description of the methods of the
EXITPAD study and its results in terms of walking dis-
tances and quality of life has recently been published. Since
rapy.
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SET and SET with feedback group were analyzed together.
SET was more effective than walking advice alone on
improving walking distance and quality of life.1 In this
secondary analysis, only the patients receiving SET (with-
out and with feedback) are analyzed.
The study was approved by the institutional review board
of the Atriummedical center and at each participating site and
registered at clinical trials.gov (NCT00279994). For this
study, a grant from The Netherlands Organisation for Health
Research andDevelopment (ZonMw), a non-profit organiza-
tion was obtained.
Patients. In general for the EXITPAD study, patients
with PAD, defined as an ankle-brachial index of0.9, who
were considered for conservative treatment were included
at the vascular outpatient clinics of 11 Dutch hospitals.
Inclusion criteria were patients having PAD according to
Fontaine stage II and an absolute claudication distance
(ACD) of 500 m as assessed by a graded standardized
treadmill test. Exclusion criteria included prior exercise
therapy, previous peripheral vascular interventions, insuffi-
cient command of the Dutch language, serious cardiopul-
monary limitations (NYHA-3-4), previous amputation,
psychiatric instability, and other serious comorbidities pro-
hibiting physical training. After the vascular surgeon had
confirmed eligibility, patients were centrally randomized
into three groups; a singleWA, SET, or SETwith feedback.
An independent researcher used a computer to generate a
randomization list with a block size of 9, stratified for each
study center. The sequence was concealed until interven-
tions had been assigned. In this secondary analysis, only the
patients referred for SET (without and with feedback) are
included.
Intervention. Patients randomized to the SET groups
Table I. Summary of the Royal Dutch Society for Physica
Facilities for SET Equipment Tre
r
Education Spe
r
Referral (general practitioner/
specialist)
Fon
c
Diagnostic process Medical history Dis
Physical examination Dis
Functional examination Ma
Therapeutic process Objectives Inc
p
s
l
Behavioral change Inc
i
Supply information Dis
Therapy mode and intensity Pri
m
(
Therapy evaluation Co
m
p
ACSM, American College of Sports Medicine; SET, supervised exercise thewere referred to local physical therapists participating in theEXITPAD study. All participating physical therapists were
trained according to the guideline on “intermittent claudi-
cation” of the Royal Dutch Society for Physical Therapy2
and therapists were asked to administer SET according to
this guideline. A summary of the guideline is presented in
Table I. Themain objectives of the guideline are to increase
maximum walking distance, aerobic endurance, and pain
tolerance, to reduce fear of pain, to improve gait pattern
and walking efficiency, to improve patient-specific activity
limitations (stair climbing, etc), to provide information,
and to induce lifestyle changes. The guideline recommends
increasing the maximumwalking distance by interval tread-
mill walking up to near-maximum pain in 5 minutes, with
at least three to five repetitions. Activities such as walking,
cycling/spinning, rowing, stepping, and sports activities in
general are recommended to increase aerobic endurance.
Patients were evaluated at baseline and at 3, 6, 9, and
12 months of follow-up, by an observer blinded to group
assignment. Patients performed a standardized graded
treadmill test at a speed of 3.2 km/h, starting at 0% incline
and increasing by 2% every 2 minutes.3 The incline and test
duration were limited, for practical reasons, to 10% and 30
minutes (1600 m), respectively. The primary outcome
measure was the change in ACD, defined as the maximal
walking distance limited by claudication pain. The second-
ary outcome measure was the change in functional claudi-
cation distance (FCD), defined as the distance at which the
patient prefers to stop because of claudication pain.
Detailed therapy evaluation and documentation sheets
were filled out by the physical therapists after 6, 12, 26, and
52 weeks of therapy, including questions about frequency,
duration, and content of the therapy.
Statistical analysis. Analysis was conducted according
to the modified intention-to-treat principle. Modified
rapy’s guideline on “intermittent claudication”
ll; cycle ergometer; indoor walking space; small-group exercise
education to provide exercise therapy according to the
mendations of the guideline is required
classification; ankle-brachial index (0.9); walking impairment;
c risk and capacity; contra-indications
specific; comorbidities; patient-specific complaints scale
specific; comorbidities
m treadmill test; gait and specific function analysis
maximum walking distance; increase aerobic endurance; increase
lerance and reduce fear of pain; improve gait pattern and
c activities (stair climbing, etc); provide information and induce
e changes
pain tolerance; reduce fear of pain; induce active lifestyle and
ve risk factors
specific; exercise therapy; lifestyle
walking up to maximum or submaximum pain; at least 6
s; at least 30 minutes per session; walking three times a week
vised or homework)
ous evaluation; extensive evaluation at least after 4 and 12 weeks;
um treadmill test, Borg Ratings of Perceived Exertions; ASCM
ale; Patient Specific Complaints Scalel The
admi
oom
cific
ecom
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ain scmeans that the analysis included all data from patients who
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ment to quantify walking distance after 12 months of
treatment. Data from patients that were lost to follow-up or
died during the study year were not included in the analysis.
Training volume (expressed in minutes) was calculated
using the following equation: frequency (days per week)
session frequency (sessions per day)  session duration
(minutes per session) total duration (weeks).4 Data were
extracted from the therapy evaluation and documentation
sheets provided by the physical therapists. In case evalua-
tion sheets were filled out partially, only available data from
the sheet were analyzed.
Categorical variables are presented as means (SD)
when normally distributed and as medians with interquar-
tile ranges (IQR) in the case of a skewed distribution.
Groups were compared using one-way analysis of variance
(ANOVA).
The guideline for physical therapists recommends start-
ing with SET, and after a few weeks, tailoring the program
to the individual needs of the patient, meaning that patients
who perform well and comply with the exercise recommen-
dations can phase down the therapy frequency sooner than
other patients. We explored whether there was a relation-
ship between the training volume offered and the effect in
terms of walking distance by analyzing training volume data
for the first 3 months, that is, the period in which the
training program had hardly been adapted to the individual
Fig. Flow chart according to CONSORT statement.CV
SET, supervised exercise therapy; WA, walking advice.needs of the patients yet. For the purpose of this analysis,the training volume offered was divided into tertiles and
each tertile was related to the median change in ACD after
3 and 12 months. Differences in walking distance between
groups were analyzed with a Wilcoxon rank-sum test.
RESULTS
Study population. Between December 2005 to May
2008, 304 patients were enrolled in the study; 102 patients
were included in the WA group, 109 patients in the SET
group, and 93 patients in the SET with feedback group
(Fig). Data from 169 patients, comprising 93 patients from
the SETwithout feedback group and 76 from the SETwith
feedback group were included in the modified intention-
to-treat analysis and analyzed in this secondary analysis.
Table II presents baseline characteristics of the 202 initially
included patients. Median maximal walking distances in-
creased significantly in both the SET without feedback
group and the SET with feedback group, from 280 to
620 m and from 240 to 580 m, respectively. However,
there was no difference in improvement between the SET
without feedback and SET with feedback groups.1
Content of the exercise program. Physical therapists
were asked to fill out therapy evaluation sheets. After 6, 12,
26, and 52 weeks, we had collected 149, 137, 134, and 113
evaluation sheets, respectively. The content of the SET
program, expressed as the number of training sessions,
duration of training sessions, and training volume, did not
rebral vascular accident; PAD, peripheral arterial disease;A,Cediffer between the two groups (Table III).
dy he
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view of the similarities in terms of improved walking dis-
tance1 and the exercise program offered in the two treat-
ment groups, data for both groups were analyzed together.
The mean number of training sessions during the first 3
months was related to the median increase in ACD.Having
a SET session once a week resulted in a median ACD
increase of 205 m after 3 months, while two and three
training sessions a week increased the ACD by a median of
273 and 245 m, respectively. Two or more SET training
sessions a week during the first 3 months yielded signifi-
Table II. Baseline characteristics
SET
Total population
n  109
a
Men – % 72.5
Age – mean (SD) 66.1 (9.0)
Body mass index – mean (SD)a 27.4 (4.2)
ABI – mean (SD) 0.67 (0.19)
ACD – median (IQR) 260 (167-395)
FCD – median (IQR) 150 (90-250)
Smoking – %
Current smoking 38.5
Former smoker 49.5
Never smoked 12.0
Unknown 0
Diabetes mellitus – % 25.7
Orthopedic disease of lower
extremities – % 14.7
Coronary heart disease – % 26.6
Cerebrovascular accident or
transient ischemic attack – % 14.7
Chronic obstructive pulmonary
disease – % 18.3
ABI, Ankle-brachial index; ACD, absolute claudication distance; FCD, funct
supervised exercise therapy.
aBody mass index is the weight in kilograms divided by the square of the bo
Table III. Content of supervised exercise program
SET
Week 6
n  79
Week 12
n  74
Week 26
n  73
We
n
Sessions per week –
mean (SD) 1.82 (0.60) 1.61 (0.72) 1.15 (0.75) 0.82
Cumulative sessions
per week – mean
(SD) 10.9 (3.6) 20.6 (7.2) 37.0 (16.6) 59.0
Duration per
session – mean
(SD) 38.6 (14.8) 41.3 (13.5) 39.6 (18.8) 36.3
Cumulative training
volumeb – mean
(SD) 431 (224) 867 (415) 1557 (924) 2740
SD, Standard deviation; SET, supervised exercise therapy; SETf, supervised
aRepeated measurements ANOVA.
bVolume  cumulative number of trainingsa duration.cantly better results in terms of walking distance after 12months than one training session a week in this period
(Table IV).
The duration of the training sessions during the first 3
months was divided into three categories: 30 minutes or
less, between 30 and 45 minutes, and over 45 minutes.
Training sessions lasting less than 30 minutes led to an
improvement in the median ACD of 230 and 240 m at 3
and 12 months, respectively. Training sessions with a
longer duration (30 minutes) yielded significantly better
increases in median ACD: from 270 to 485 m for sessions
lasting between 30 and 45 minutes and from 290 to 390 m
SET SET with feedback SET with feedback
d population
 93
total population
n  93
analyzed population
n  76
72.0 60.2 60.5
(8.6) 65.6 (10.5) 65.6 (10.3)
(4.3) 28.2 (5.1) 27.8 (4.6)
(0.18) 0.67 (0.16) 0.68 (0.16)
(170-405) 250 (160-340) 240 (160-340)
(90-265) 150 (100-230) 140 (100-228)
39.8 41.9 48.7
48.4 46.2 42.1
11.8 4.3 3.9
0 7.5 5.3
26.9 18.3 15.8
11.8 17.2 18.4
24.7 20.4 18.4
17.2 9.7 11.8
19.4 17.2 18.4
laudication distance; IQR, interquartile range; SD, standard deviation; SET,
ight in meters.
SET with feedback P valuea
SET
and
SETf
Week 6
n  70
Week 12
n  63
Week 26
n  61
Week 52
n 54
) 1.64 (0.58) 1.41 (0.69) 1.00 (0.69) 0.75 (0.66) 0.34
) 9.8 (3.5) 18.4 (7.0) 33.5 (14.8) 55.6 (29.5) 0.58
) 39.7 (15.0) 39.6 (17.3) 37.7 (18.2) 36.7 (19.5)
0) 403 (189) 799 (404) 1481 (868) 2479 (1628) 0.43
se therapy with feedback.nalyze
n
65.9
27.4
0.67
280
160
ional cek 52
 59
(0.74
(32.2
(21.5
(184
exercifor sessions lasting over 45 minutes, compared with train-
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.021 after 3 months and P  .017 after 12 months).
To explore the relationship between the training vol-
ume offered, which depends on frequency and duration,
and the effect of therapy in terms of walking distance, we
divided training volume into tertiles. In the first tertile, the
training volume offered in the first 3 months ranged from 0
to 590 minutes, in the second tertile from 591 to 1000
minutes, and in the third tertile from 1001 to 2160 min-
utes. Table IV relates the tertiles of training volume to the
median change in ACD after 3 and 12months. The median
change in walking distance in the first tertile was 158 m
after 3months and 218m after 12months. Across the three
tertiles, the median change in walking distance significantly
improved when comparing the tertile with the lowest train-
ing volume with the two tertiles with the higher training
volumes (with median changes of 300 and 470 m, and 265
and 445 m in the second and third tertiles after 3 and 12
months, respectively) (P .002 at 3 months and P .003
at 12 months). This indicates that offering a training vol-
ume higher than 590 minutes in the first 3 months was
associated with greater improvement in walking distance, in
the short term as well as after 12 months.
Additional findings. No difference in the improve-
Table IV. Cumulative training volume and mean number
SET without feedback and SET with feedback groups
Mean number of tr
1
n  44
Median change in ACD between 3
months and baseline 205 (80-398)
Median change in ACD between
12 months and baseline 245 (115-445)
Duration of training
30 minutes
n  51
Median change in ACD between 3
months and baseline 230 (100-350)
Median change in ACD between
12 months and baseline 240 (130-510)
Cumulative trainin
Tertile 1
0-590
n  40
Median change in ACD between 3
months and baseline 158 (81-300)
Median change in ACD between
12 months and baseline 218 (115-448)
ACD, Absolute claudication distance; SET, supervised exercise therapy.
The number of analyzed patients varies because in some cases evaluation fo
aWilcoxon rank-sum test.ment in walking distance was found between patients usingwalking as the sole mode of exercise and patients perform-
ing a combination of exercises including cycling/spinning,
rowing, stepping, and sports activities in general (Table V).
Furthermore, there was no significant difference in im-
provement in walking distance between individual training
and group training.
Smoking behavior at baseline was related to the median
increase in ACD after 3 and after 12 months. Non- or
ex-smokers showed a median ACD increase of 273 m after
3 months, while smokers increased their ACD by a median
of 245. After 12 months, this was 405 m for non- or
ex-smokers and 310 m for smokers (Table VI).
DISCUSSION
The results of this study suggest that the training
volume offered in the first 3 months of supervised exercise
therapy for intermittent claudication is related to the level
of improvement in terms of walking distance at 3 and 12
months. Good results were observed with two or more
training sessions per week each lasting more than 30 min-
utes. However, it must be noted that no significant further
improvement was seen between two or more training ses-
sions a week, nor between sessions lasting 30 to 45 minutes
aining sessions during the first 3 months, combining the
g sessions per week during the first 3
months
P valuea 1 session vs
2 or more sessions
2 3 or more
n  81 n  10
(165-545) 245 (155-524) .052
(195-1100) 425 (120-719) .004
s per week during the first 3 months
P valuea 30 minutes
vs 30 minutes
een 30 and
minutes 45 minutes
 36 n  45
155-733) 290 (150-510) .021
267-1138) 390 (170-1165) .017
umea of therapy in the first 3 months
P valuea tertile 1 vs
tertiles 2 and 3
Tertile 2
591-1000
Tertile 3
1001-2160
n  45 n  44
(177-780) 265 (173-475) .002
(210-1160) 445 (165-900) .003
ere not filled out completely, and only available data were included.of tr
ainin
273
480
session
Betw
45
n
270 (
485 (
g vol
300
470
rms wand those lasting over 45 minutes.
JOURNAL OF VASCULAR SURGERY
Volume 52, Number 5 Nicolaï et al 1231The results of our study are generally in line with those
of two meta-analyses on optimal exercise SET training.4,5
However, these meta-analyses found a frequency of three
times a week4 or three times a week or more5 to be optimal.
Moreover, one study suggested that an optimized training
program consists of a total training volume of 2000 min-
utes,4 whereas our results suggest a minimum training
volume of 590 minutes within the first 3 months. Since the
content of the therapy in our study was tailored to the pa-
tients’ needs after 3 months, we could not evaluate the rela-
tion between total training volume and the effect on walking
Table V. Features of supervised exercise programs
during the first 3 months, combining the SET without
feedback and SET with feedback groups
Walking
exercise only
Combination of
exercisesa P
valuebn  60 n  75
Median change in ACD
between 3 months
and baseline 280 (128-492) 252 (150-460) .692
Median change in ACD
between 12 months
and baseline 405 (173-900) 405 (173-900) .896
Individual Group training
n  97 n  33
Median change in ACD
between 3 months
and baseline 265 (153-508) 220 (115-400) .313
Median change in ACD
between 12 months
and baseline 410 (170-1065) 300 (150-890) .382
ACD, Absolute claudication distance.
The number of analyzed patients varies because in some cases, evaluation
forms were not filled out completely, and only available data were included.
aConsisting of cycling/spinning, rowing, stepping, and sports activities in
general.
bWilcoxon rank-sum test.
Table VI. Smoking behavior at baseline and influence on
ACD
Former smoker
or never smoker Current smoker P
valuean  91 n  74
Median change in
ACD between
3 months and
baseline 273 (150-630) 245 (118-373) .224
Median change in
ACD between
12 months and
baseline 405 (160-1100) 310 (130-571) .175
ACD, Absolute claudication distance.
The number of analyzed patients varies because in some cases, evaluation
forms were not filled out completely, and only available data were included.
aWilcoxon rank-sum test.distance.Results of studies using other exercise modalities than
walking, for example, polestriding6 and upper- and lower-
limb ergometry,7 show improvements in walking ability in
patients with PAD. These results suggest that any kind of
training could improve walking distance for these patients.
Our data show no difference between patients using walk-
ing as the sole mode of exercise and patients performing
different exercises as well as walking. Researchers have
suggested that resistance training does not augment the
response to a walking exercise program.8 The added value
of other types of exercises than walking in terms of im-
proved walking distance is an interesting topic for further
research, especially since it is imaginable that varying exer-
cises can increase patients’ compliance with exercise pro-
grams and facilitate the incorporation of exercise in their
daily lives.
The nature of the Dutch guidelines for physical thera-
pists does not allow us to determine an optimal duration of
the program: the guideline recommends tailoring the pro-
gram to the individual patient’s needs, with training fre-
quency for patients responding well to the exercise pro-
gram being phased down sooner than that of patients
showing minimal response. The fact that the therapists
worked according to the guideline represented a limitation
to our study. It was the physical therapists who decided on
the therapy frequency and duration for each patient, which
may have led to selection bias. There is no consensus in the
literature regarding the minimum duration of SET pro-
grams either, with recommendations varying from 10 to 14
weeks9 and 12 to 24 weeks4 to more than 26 weeks.5 A
randomized trial evaluating various durations and frequen-
cies would be required to address this question satisfactorily
and optimize the intervention.
Since the Dutch guidelines recommend walking up to
sub maximum pain, we were unable to compare between
high- and low-intensity programs. Interestingly, one study
reported in the literature suggested that the efficacy of
low-intensity exercise (walking up to 40% of maximum
workload) is similar to that of high-intensity exercise (walk-
ing up to 80% of maximum workload).10 It has also been
suggested that walking below the pain threshold level is
effective in terms of increasing walking distances.11,12
Several studies have reported conflicting results regard-
ing patient-related variables predicting walking distance
after SET.13-16 A recent study identified baseline ACD,
body mass index, and current smoking as possible factors
influencing treatment outcome.14 Cognitive factors, such
as patients’ belief in the effectiveness of SET, are also
reported to be positively associated with the improvement
in walking distance.13 Patients with PAD in combination
with a type D personality, defined as having a tendency to
have negative emotions and being socially inhibited, re-
mained more severely impaired after therapy (conservative
and/or invasive) than other patients.17
In The Netherlands, where this study was conducted,
intermittent claudication is one of the chronic diseases that
is considered for physical therapy for the maximal duration
of 1 year. Standard reimbursement, which is financed by the
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patient from the 10th session through the period of one
year. Reimbursement for the first nine sessions is available if
the patient has an additional and voluntary health insur-
ance. At the moment, the minimal advised charge for one
physiotherapeutic session is $32.07 (www.fysionet.nl). In
an earlier analysis, the mean cost for 1 year of physiotherapy
was estimated at $1920.00 per year.18
In conclusion, our study suggests that a supervised
exercise program consisting of two or more training ses-
sions a week each lasting over 30minutes during the first 12
weeks of a program that is later tailored to the patient’s
needs, with a maximum duration of 1 year, seems to
optimize walking distance after 3 and 12 months.
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